Table 1 of Wang, Mol Vis 2008; 14:105-113.
Gene | Treatment | 0 min | 10 min | 20 min | 30 min | 50 min | 80 min | 2 h | 12 h | 24 h | 48 h |
---|---|---|---|---|---|---|---|---|---|---|---|
c-jun | 0.025% BA versus 0.0025% BA | 0.88 | 0.051 | 0.003 | <0.0005 | 0.003 | 0.009 | 0.105 | 0.002 | 0.602 | 0.059 |
c-jun | 0.1 mg/ml TA versus 0.0025% BA | 0.886 | <0.0005 | <0.0005 | <0.0005 | <0.0005 | 0.004 | 0.003 | 0.001 | 0.073 | 0.571 |
c-jun | 1 mg/ml TA versus 0.025% BA | 0.891 | <0.0005 | <0.0005 | 0.001 | 0.452 | 0.051 | <0.0005 | 0.361 | 0.075 | 0.080 |
c-fos | 0.025% BA versus 0.0025% BA | 0.883 | <0.0005 | <0.0005 | <0.0005 | <0.0005 | 0.001 | 0.274 | 0.011 | 0.044 | 0.029 |
c-fos | 0.1 mg/ml TA versus 0.0025% BA | 0.960 | <0.0005 | <0.0005 | <0.0005 | 0.149 | 0.423 | 0.368 | 0.114 | 0.358 | 0.969 |
c-fos | 1 mg/ml TA versus 0.025% BA | 0.660 | <0.0005 | 0.002 | <0.0005 | <0.0005 | 0.002 | 0.245 | 0.933 | 0.607 | 0.072 |
c-myc | 0.025% BA versus 0.0025% BA | 0.715 | 0.090 | 0.490 | 0.005 | <0.0005 | 0.461 | 0.152 | 0.060 | 0.070 | 0.006 |
c-myc | 0.1 mg/ml TA versus 0.0025% BA | 0.596 | 0.005 | 0.004 | <0.0005 | <0.0005 | 0.001 | 0.005 | 0.005 | 0.070 | 0.003 |
c-myc | 1 mg/ml TA versus 0.025% BA | 0.814 | 0.804 | 0.005 | 0.001 | <0.0005 | 0.442 | 0.008 | 0.007 | 0.065 | 0.081 |
caspase 3 | 0.025% BA versus 0.0025% BA | 0.902 | 0.683 | 0.089 | 0.070 | 1.000 | 0.041 | 0.154 | 0.024 | 0.099 | 0.033 |
caspase 3 | 0.1 mg/ml TA versus 0.0025% BA | 1.000 | 0.054 | 0.114 | 0.024 | 0.04 | 0.01 | 0.001 | <0.0005 | 0.002 | <0.0005 |
caspase 3 | 1 mg/ml TA versus 0.025% BA | 0.692 | 0.675 | 0.087 | 0.027 | 0.006 | 0.001 | <0.0005 | <0.0005 | 0.002 | <0.0005 |
p53 | 0.025% BA versus 0.0025% BA | 0.305 | 0.21 | 0.709 | 0.516 | 0.152 | 0.057 | 0.057 | 0.51 | 0.189 | 0.718 |
p53 | 0.1 mg/ml TA versus 0.0025% BA | 0.678 | 0.067 | 0.059 | 0.25 | 0.003 | 0.001 | <0.0005 | <0.0005 | <0.0005 | <0.0005 |
p53 | 1 mg/ml TA versus 0.025% BA | 0.219 | 0.065 | 0.026 | 0.1 | 0.001 | 0.001 | <0.0005 | 0.007 | <0.0005 | <0.0005 |